The cellular source of interleukin-6 during Listeria infection
- PMID: 8500900
- PMCID: PMC280893
- DOI: 10.1128/iai.61.6.2626-2631.1993
The cellular source of interleukin-6 during Listeria infection
Abstract
The cellular source of interleukin-6 (IL-6) during infection of mice with Listeria monocytogenes was investigated both in vitro and in vivo. Peritoneal cells taken at intervals from infected mice and cultured in vitro without added stimulus produced high titers of IL-6 peaking 2 days postinfection in a time course similar to that observed in vivo. Adherent cells with the morphology of macrophages were a major source of this IL-6. Spleen cells similarly harvested at intervals and cultured with heat-killed Listeria or heat-killed Brucella organisms as specific and nonspecific stimuli, respectively, showed two distinct IL-6 responses: (i) an early-phase response up to 5 days after infection when IL-6 production was elicited by either a specific or nonspecific stimulus, and when depletion of T cells had no effect, and (ii) a later response 7 to 10 days after infection when very high levels of IL-6 were produced in response to a specific stimulus. This response was lost when T cells were depleted in vitro or in vivo or in spleen cell cultures from mice with severe combined immunodeficiency. However, studies in vivo failed to show an important role for T cells governing serum IL-6. We conclude that most of IL-6 detected in vivo is produced by nonlymphocytes. Whether IL-6 produced by T lymphocytes in local foci of infection has any role in resolution of that infection is unknown.
Similar articles
-
Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes.Eur J Immunol. 1996 Feb;26(2):356-64. doi: 10.1002/eji.1830260214. Eur J Immunol. 1996. PMID: 8617304
-
Role of IL-6 in activation of T cells for acquired cellular resistance to Listeria monocytogenes.J Immunol. 1994 Jun 1;152(11):5375-80. J Immunol. 1994. PMID: 8189056
-
Mechanism of murine Vgamma1+ gamma delta T cell-mediated innate immune response against Listeria monocytogenes infection.Eur J Immunol. 2002 Apr;32(4):928-35. doi: 10.1002/1521-4141(200204)32:4<928::AID-IMMU928>3.0.CO;2-I. Eur J Immunol. 2002. PMID: 11920558
-
Recombinant interleukin-6 protects mice against experimental bacterial infection.Infect Immun. 1992 Oct;60(10):4402-6. doi: 10.1128/iai.60.10.4402-4406.1992. Infect Immun. 1992. PMID: 1398949 Free PMC article.
-
Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia.Infect Immun. 1995 Jun;63(6):2262-8. doi: 10.1128/iai.63.6.2262-2268.1995. Infect Immun. 1995. PMID: 7768607 Free PMC article.
Cited by
-
Role of interleukin-6 in T-cell activation during primary and secondary infection with Listeria monocytogenes.Infect Immun. 1995 Jul;63(7):2790-2. doi: 10.1128/iai.63.7.2790-2792.1995. Infect Immun. 1995. PMID: 7790102 Free PMC article.
-
Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine.Infect Immun. 1999 Nov;67(11):5747-54. doi: 10.1128/IAI.67.11.5747-5754.1999. Infect Immun. 1999. PMID: 10531224 Free PMC article.
-
Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice.Immunology. 1994 Jul;82(3):361-4. Immunology. 1994. PMID: 7959868 Free PMC article.
-
Salmonella typhi stimulation of human intestinal epithelial cells induces secretion of epithelial cell-derived interleukin-6.Infect Immun. 1997 Feb;65(2):395-404. doi: 10.1128/iai.65.2.395-404.1997. Infect Immun. 1997. PMID: 9009288 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical